Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients

Growth Hormone and IGF Research

Volumn 22, Issue 3-4, 2012, Pages 134-138

  Bedogni, G ^a   Giannone, G ^b   Maghnie, M ^c   Giacomozzi, C ^d   Di Iorgi, N ^c   Pedicelli, S ^d   Peschiaroli, E ^d   Melioli, G ^c   Muraca, M ^b   Cappa, M ^b   Cianfarani, S ^b,d  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

GH deficiency; Hypopituitarism; Insulin like growth factor I; Reference ranges

Indexed keywords

SOMATOMEDIN C;

ADOLESCENT; ADULT; AGE; ARTICLE; BIOASSAY; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHILD; ENZYME LABELED CHEMILUMINISCENT IMMUNOMETRIC ASSAY; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PEDIATRICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INPATIENTS; INSULIN-LIKE GROWTH FACTOR I; ITALY; LUMINESCENT MEASUREMENTS; MALE; OUTPATIENTS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 84863785341     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.04.005     Document Type: Article

References (25)

1. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16(2):143-163.
2. Rubin R., Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 1995, 73(3):311-331.
3. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75(1):73-82.
4. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22(1):53-74.
5. Moore D.C., Ruvalcaba R.H., Smith E.K., Kelley V.C. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents. Horm. Res. 1982, 16(1):49-55.
6. Federico G., Cianfarani S. Usefulness of serum insulin-like growth factor I assessment in the diagnosis of childhood-onset growth hormone deficiency. Horm. Res. Paediatr. 2010, 74(2):145-148.
7. Cianfarani S., Liguori A., Boemi S., Maghnie M., Iughetti L., Wasniewska M., et al. Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J. Clin. Endocrinol. Metab. 2005, 90(11):6028-6034.
8. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 2001, 86(5):1868-1870.
9. Cohen P., Rogol A.D., Howard C.P., Bright G.M., Kappelgaard A.M., Rosenfeld R.G., et al. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J. Clin. Endocrinol. Metab. 2007, 92(7):2480-2486.
10. Clemmons D.R. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin. Chem. 2011, 57(4):555-559.
11. Wei Y., Pere A., Koenker R., He X. Quantile regression methods for reference growth charts. Stat. Med. 2006, 25(8):1369-1382.
12. Royston P., Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology-with an emphasis on fractional polynomials. Methods Inf. Med. 2005, 44(4):561-571.
13. Frystyk J., Freda P., Clemmons D.R. The current status of IGF-I assays-a 2009 update. Growth Horm. IGF Res. 2010, 20(1):8-18.
14. Brabant G., von zur Mühlen A., Wüster C., Ranke M.B., Kratzsch J., Kiess W., et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 2003, 60(2):53-60.
15. Elmlinger M.W., Kühnel W., Weber M.M., Ranke M.B. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 2004, 42(6):654-664.
16. Kong A.P., Wong G.W., Choi K.C., Ho C.S., Chan M.H., Lam C.W., et al. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents. Clin. Biochem. 2007, 40(15):1093-1099.
17. Xu S., Gu X., Pan H., Zhu H., Gong F., Li Y., et al. Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence. Endocr. J. 2010, 57(3):221-228.
18. Chaler E.A., Meazza C., Guercio G., Maceiras M., Rivarola M.A., Laarej K., et al. Serum IGF-I and IGFBP-3 reference values from a chemiluminescent assay in normal children and adolescents of Hispanic and Italian origin: presence of sexual dimorphism in IGF-I values. J. Pediatr. Endocrinol. Metab. 2009, 22(12):1127-1135.
19. Pryce J.D. Level of haemoglobin in whole blood and red blood-cells, and proposed convention for defining normality. Lancet 1960, 2(7146):333-336.
20. Giavarina D., Dorizzi R.M., Fortunato A. Indirect estimation of pediatric Health Related Limits for serum thyrotropin using the ADVIA Centaur analyzer. Clin. Biochem. 2007, 40(15):1143-1149.
21. Jopling J., Henry E., Wiedmeier S.E., Christensen R.D. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics 2009, 123(2):e333-e337.
22. Clayton P.E., Hall C.M. Insulin-like growth factor I levels in healthy children. Horm. Res. 2004, 62(Suppl. 1):2-7.
23. Bereket A., Turan S., Omar A., Berber M., Ozen A., Akbenlioglu C., et al. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm. Res. 2006, 65(2):96-105.
24. Löfqvist C., Andersson E., Gelander L., Rosberg S., Blum W.F., Albertsson Wikland K. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J. Clin. Endocrinol. Metab. 2001, 86(12):5870-5876.
25. Friedrich N., Alte D., Völzke H., Spilcke-Liss E., Lüdemann J., Lerch M.M., et al. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm. IGF Res. 2008, 18(3):228-237.